Splenic Irradiation and Late Volume Changes Following Stereotactic Ablative Radiotherapy (SABR) for Adrenal Tumors

被引：0
|
作者：
Giraud, N. [1 ]
Schneiders, F. L. [1 ]
de Koste, J. R. van Sornsen [1 ]
Palacios, M. A. [1 ]
Senan, S. [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2844
引用
收藏
页码：E385 / E386
页数：2
相关论文
共 50 条
  • [1] Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases
    Hamidi, Oksana
    Miljanic, Mihailo
    Tumyan, Gayane
    Christie, Alana
    Mirfakhraee, Sasan
    Ali, Sadia
    Dohopolski, Michael
    Gottumukkala, Sujana
    Brugarolas, James
    Timmerman, Robert
    Hannan, Raquibul
    CANCERS, 2024, 16 (18)
  • [2] Dose-Dependent Splenic Volume Changes during Adrenal Adaptive Stereotactic Ablative Radiotherapy
    Chen, H.
    Bohoudi, O.
    de Koste, J. Van Sornsen
    Spoelstra, F.
    Slotman, B.
    Palacios, M.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S309 - S309
  • [3] Dose-Dependent Splenic Volume Changes during Adrenal Adaptive Stereotactic Ablative Radiotherapy
    Chen, H.
    Bohoudi, O.
    de Koste, J. R. van Sornsen
    Spoelstra, F.
    Slotman, B. J.
    Palacios, M.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E369 - E370
  • [4] DOSE-DEPENDENT SPLENIC VOLUME CHANGES DURING ADRENAL ADAPTIVE STEREOTACTIC ABLATIVE RADIOTHERAPY
    Chen, Hanbo
    Bohoudi, Omar
    de Koste, John van Sornsen
    Spoelstra, Femke
    Slotman, Ben
    Palacios, Miguel
    Senan, Suresh
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S82 - S83
  • [5] Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
    Binkley, Michael S.
    Shrager, Joseph B.
    Chaudhuri, Aadel
    Popat, Rita
    Maxim, Peter G.
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    RADIATION ONCOLOGY, 2016, 11
  • [6] Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
    Michael S. Binkley
    Joseph B. Shrager
    Aadel Chaudhuri
    Rita Popat
    Peter G. Maxim
    David Benjamin Shultz
    Maximilian Diehn
    Billy W. Loo
    Radiation Oncology, 11
  • [7] The Future of Stereotactic Ablative Radiotherapy (SABR)
    Loo, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S283 - S284
  • [8] Late toxicity following stereotactic radiotherapy (SABR) for central and ultracentral lung tumors
    Tekatli, H.
    Lagerwaard, F.
    van Eekelen, R.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S493 - S494
  • [9] Stereotactic ablative Radiotherapy (SABR) for Adrenal Metastases: high Efficacy with low Toxicity
    Koos, V
    Kretschmer, M.
    Dahle, J.
    Sabatino, M.
    Feine, D.
    Wuerschmidt, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S43 - S44
  • [10] Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay
    Ronden, Merle I.
    Palma, David
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 855 - 862
12345